CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Company Snapshot
Shanghai Fosun Pharmaceutical (Group) Company Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Fosun Pharmaceutical (Group) Company Limited with three other companies in this sector in China: Tasly Pharmaceutical Group Company Limited (2017 sales of 16.09 billion Chinese Renmimbi [US$2.32 billion] of which 57% was Medicine Commerce), Humanwell Healthcare Group Co Ltd (15.45 billion Chinese Renmimbi [US$2.22 billion] of which 99% was Medication & Health Products), and Guangzhou Baiyunshan Pharmceutical Holdings Co Ltd (20.95 billion Chinese Renmimbi [US$3.01 billion] of which 41% was Health).

Sales Analysis. During the year ended December of 2017, sales at Shanghai Fosun Pharmaceutical (Group) Company Limited were 18.36 billion Chinese Renmimbi (US$2.64 billion). This is an increase of 26.6% versus 2016, when the company's sales were 14.51 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shanghai Fosun Pharmaceutical (Group) Company Limited (and since 2012, sales have increased a total of 152%). Sales of Pharmaceutical Manufacturing and R&d saw an increase of 28.5% in 2017, from 10.15 billion Chinese Renmimbi to 13.04 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Fosun Pharmaceutical (Group) Company Limited
  Stock Performance Chart for Shanghai Fosun Pharmaceutical (Group) Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 27.59
(Figures in Chinese Renmimbi)
1 Week 0.3%   13 Weeks -3.5%  
4 Weeks -10.0%   52 Weeks -33.0%  
 
Shanghai Fosun Pharmaceutical (Group) Company Limited Key Data:
  Ticker: 600196 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 18,361,608,000
(Year Ending Jan 2018).
Employees: 28,848
  Currency: Chinese Renmimbi Market Cap: 68,838,730,093
  Fiscal Yr Ends: December Shares Outstanding: 2,495,060,895
  Share Type: A Gu Closely Held Shares: 1,008,433,615
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.